We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESSA
2701
DELISTED
ESSA Bancorp
ESSA
| $227K | ﹤0.01% |
16,317
-7,595
| -32% | -$98K |
|
|
OTRK
2702
DELISTED
Ontrak
OTRK
| $227K | ﹤0.01% |
+102
| New | +$205K |
|
|
FNHC
2703
DELISTED
FedNat Holding Company Common Stock
FNHC
| $227K | ﹤0.01% |
20,474
+3,815
| +23% | +$44.5K |
|
|
ARD
2704
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $227K | ﹤0.01% |
17,566
+3,231
| +23% | +$40.3K |
|
2705
Baidu
BIDU
$37.2B
| $226K | ﹤0.01% |
+1,887
| New | +$202K |
|
|
KIN
2706
DELISTED
Kindred Biosciences, Inc.
KIN
| $226K | ﹤0.01% |
50,362
+2,350
| +5% | +$10.5K |
|
2707
Investar Holding Corp
ISTR
$414M
| $225K | ﹤0.01% |
15,533
-2,880
| -16% | -$36.7K |
|
2708
Weyco Group
WEYS
$440M
| $225K | ﹤0.01% |
10,436
-1,397
| -12% | -$27.1K |
|
|
CVLY
2709
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $225K | ﹤0.01% |
16,280
-6,986
| -30% | -$93.2K |
|
|
PRVL
2710
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $224K | ﹤0.01% |
+15,016
| New | +$231K |
|
2711
Superior Group of Companies
SGC
$225M
| $223K | ﹤0.01% |
16,654
-2,240
| -12% | -$21.2K |
|
2712
BayCom
BCML
$333M
| $222K | ﹤0.01% |
17,181
+1,875
| +12% | +$23.2K |
|
2713
First Business Financial Services
FBIZ
$595M
| $222K | ﹤0.01% |
13,478
-3,785
| -22% | -$59.2K |
|
|
CBIO
2714
Crescent Biopharma
CBIO
$626M
| $221K | ﹤0.01% |
589
+147
| +33% | +$41.6K |
|
2715
Parke Bancorp
PKBK
$405M
| $221K | ﹤0.01% |
16,333
+1,700
| +12% | +$21.9K |
|
2716
Vale
VALE
$62.6B
| $221K | ﹤0.01% |
+21,427
| New | +$196K |
|
2717
Westwood Holdings Group
WHG
$190M
| $221K | ﹤0.01% |
14,037
+905
| +7% | +$17.2K |
|
|
USX
2718
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $221K | ﹤0.01% |
36,889
+2,925
| +9% | +$13.4K |
|
2719
Foster
FSTR
$432M
| $219K | ﹤0.01% |
17,162
+1,390
| +9% | +$17.9K |
|
|
KDNY
2720
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $219K | ﹤0.01% |
18,985
+1,790
| +10% | +$24.7K |
|
2721
Northeast Bank
NBN
$1.14B
| $217K | ﹤0.01% |
12,366
+830
| +7% | +$12.6K |
|
|
PARAA
2722
DELISTED
Paramount Global Class A
PARAA
| $217K | ﹤0.01% |
+8,487
| New | +$189K |
|
2723
Philips
PHG
$26.1B
| $215K | ﹤0.01% |
+5,666
| New | +$197K |
|
2724
American Superconductor
AMSC
$1.59B
| $214K | ﹤0.01% |
26,373
+3,669
| +16% | +$24K |
|
|
KALV
2725
DELISTED
KalVista Pharmaceuticals
KALV
| $214K | ﹤0.01% |
17,650
+6,923
| +65% | +$73.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.